Smad3 is the chief transcription factor of TGF-β, and the elevation of its phosphorylation levels in human T2DM islets indicates an autocrine role for TGF-β/Smad3 signaling in the apoptosis of β-cells; the same results are observed in diabetic mice [137]. Here, SMAD3 is linked to type 2 diabetes mellitus.